Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04605744 · ClinicalTrials.gov registry record · NA
Peri-procedural Smoking Cessation Program in Patients With Chronic Pain
A NA study, sponsored by The Cooper Health System.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT04605744: Clinical Trial NA study, sponsored by The Cooper Health System.
NCT04605744 is a NA study that was terminated before completion, run by The Cooper Health System. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04605744, a NA study, was terminated before completion, sponsored by The Cooper Health System.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This single arm study will assess whether smoking cessation counseling offered to chronic pain patients is effective in reducing pain and cigarette use.
Primary Outcome
Visual analogue pain score
Interventions
- BEHAVIORAL Smoking cessation counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2020-02-18 |
| Est. Completion | 2021-12-06 |
| Phase | NA |
Why NCT04605744 stopped before completion
NCT04605744 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Smoking cessation counseling is the first listed.
NCT04605744 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04605744 about?
NCT04605744 is a clinical study titled "Peri-procedural Smoking Cessation Program in Patients With Chronic Pain". This single arm study will assess whether smoking cessation counseling offered to chronic pain patients is effective in reducing pain and cigarette use.
What is the current status of trial NCT04605744?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2020-02-18. Estimated completion is 2021-12-06.
What interventions are being tested in trial NCT04605744?
The interventions under investigation include: Smoking cessation counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT04605744?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04605744's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI